Over time, some HIV-infected individuals develop antibodies that show great potency against diverse strains of the virus. Passive transfer of such antibodies can protect against infection in monkeys, so there is great interest in creating a vaccine that could elicit such antibodies in vaccinated individuals (see the Perspective by Korber and Gnanakaran).
展开▼
